Stobadine was recognized early in its development as having antioxidant pro
perties. A number of laboratories found associations between the antioxidan
t properties of stobadine and its potential beneficial effects. We found th
at stobadine acted as an antioxidant in a modification of an oxygen radical
absorbance capacity ORAC) assay. Similar results were observed with other
drugs, including tirilazad and pramipexole. We suggest that stobadine and c
ertain other drugs exhibit antioxidant properties in both hydrophilic and h
ydrophobic environments. Other drugs have been developed for their antioxid
ant properties and some currently marketed drugs have antioxidant propertie
s. Although they may not have been explicitly sought during development, at
least some of the beneficial effects may be related to antioxidant propert
ies and/or scavenging of free radicals. Because stobadine was one of the fi
rst drugs for which useful properties were associated with its antioxidant
actions, stobadine may be seen as a bellwether of a broader view of pharmac
ological actions a view that encompasses antioxidant properties as a useful
basis of therapeutic effects.